{
    "clinical_study": {
        "@rank": "8065", 
        "arm_group": [
            {
                "arm_group_label": "Non-obese individuals", 
                "arm_group_type": "Active Comparator", 
                "description": "Daily consumption of 12 oz lowfat yogurt or soy pudding for 9 weeks."
            }, 
            {
                "arm_group_label": "Obese individuals", 
                "arm_group_type": "Experimental", 
                "description": "Consumption of 12 oz of soy pudding or low fat dairy yogurt daily for 9 weeks."
            }
        ], 
        "brief_summary": {
            "textblock": "The main objective of this work is to conduct a clinical trial in obese and non-obese\n      individuals testing the ability of low-fat dairy yogurt to improve gastrointestinal health\n      and reduce chronic inflammation. Our central hypothesis is that short and long-term\n      consumption of low-fat dairy yogurt will reduce inflammation to a greater extent in obese\n      individuals by improving intestinal barrier function."
        }, 
        "brief_title": "Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt", 
        "condition": [
            "Intestinal Barrier Function", 
            "Chronic Inflammation"
        ], 
        "condition_browse": {
            "mesh_term": "Inflammation"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  premenopausal women\n\n          -  BMI from 18.5-27 and 30-40 kg/m2\n\n          -  resting blood pressure <140/90 mmHg\n\n          -  not taking medication to control hypertension\n\n          -  stable body weight for the previous 2 months\n\n          -  willing to maintain a normal exercise level and avoid exercise 24 h prior to blood\n             sampling\n\n          -  willing to avoid yogurt and probiotic-containing foods or consume 2 servings of\n             yogurt for the duration of the study\n\n        Exclusion Criteria:\n\n          -  previous diagnoses of CVD, diabetes, or arthritis (except for osteo-arthritis)\n\n          -  currently being treated for cancer (i.e., chemotherapy, radiation therapy)\n\n          -  prescribed estrogen replacement therapy\n\n          -  practicing weight-loss, vegetarian, kosher,  or vegan diets\n\n          -  currently taking dietary supplements\n\n          -  exceed alcohol consumption more than moderate drinking (1 drink/day or a total of\n             7/week)\n\n          -  actively using antibiotics\n\n          -  taking anti-inflammatory drugs\n\n          -  have allergies to soy, egg or milk\n\n          -  perimenopausal or menopausal symptoms"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "132", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01686204", 
            "org_study_id": "H12-168"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Non-obese individuals", 
                    "Obese individuals"
                ], 
                "description": "Consumption of 12 oz of low fat dairy yogurt daily for 9 weeks", 
                "intervention_name": "Low fat dairy yogurt", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": [
                    "Non-obese individuals", 
                    "Obese individuals"
                ], 
                "description": "Consumption of 12 oz of low fat soy pudding daily for 9 weeks.", 
                "intervention_name": "Soy pudding", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Yogurt", 
            "Intestine", 
            "Inflammation", 
            "Obese"
        ], 
        "lastchanged_date": "May 21, 2014", 
        "link": {
            "description": "University of Connecticut Department of Nutritional Sciences Ongoing Research Studies", 
            "url": "http://www.cag.uconn.edu/nutsci/nutsci/studies.html"
        }, 
        "location": {
            "contact": {
                "email": "bradley.bolling@uconn.edu", 
                "last_name": "Bradley W Bolling, PhD", 
                "phone": "860-486-2180"
            }, 
            "facility": {
                "address": {
                    "city": "Storrs", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06269"
                }, 
                "name": "Department of Nutritional Sciences"
            }, 
            "investigator": {
                "last_name": "Bradley W Bolling, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Reduction of Obesity-Associated Intestinal Inflammation by Low-Fat Dairy Yogurt", 
        "other_outcome": [
            {
                "measure": "Monocyte gene expression", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma lipopolysaccharide binding protein", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma endotoxin", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma core antibodies to endotoxin", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma endocannabinoids", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma IL-10", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma C-reactive protein", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma Tumor Necrosis Factor-alpha", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }, 
            {
                "measure": "Plasma tumor necrosis factor receptor", 
                "safety_issue": "No", 
                "time_frame": "Baseline, 9 weeks"
            }
        ], 
        "overall_contact": {
            "email": "uconn.yogurt@gmail.com", 
            "last_name": "Diana Dimarco", 
            "phone": "860-420-9841"
        }, 
        "overall_official": {
            "affiliation": "University of Connecticut", 
            "last_name": "Bradley W Bolling, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Following a high fat, high calorie meal at baseline and 9 wk", 
            "measure": "Plasma sCD14", 
            "safety_issue": "No", 
            "time_frame": "Change from baseline at 3, 6, and 9 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01686204"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Connecticut", 
            "investigator_full_name": "Bradley Bolling", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Following a high fat, high calorie  meal at baseline and 9 wk", 
            "measure": "Plasma IL-6", 
            "safety_issue": "No", 
            "time_frame": "Baseline, 3, 6, 9 weeks"
        }, 
        "source": "University of Connecticut", 
        "sponsors": {
            "collaborator": {
                "agency": "Dairy Research Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Connecticut", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}